Picture of C&R Research logo

359090 C&R Research Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for C&R Research, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3,9285,5603,3591,021
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items9607949152,630
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1,566-3,012-3,964-2,708-7,863
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities2,2492,5233,5122,839-3,068
Capital Expenditures-1,281-1,258-213-809-285
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items14,772-8,880-1,5842,491-1,312
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities13,491-10,138-1,7971,682-1,597
Financing Cash Flow Items-3.522630-195
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-919-5,316-9592311,363
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash14,821-12,9377474,860-3,272